AFYX Therapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
AFYX Therapeutics General Information
Description
Operator of a drug delivery company intended to develop a pipeline of targeted treatments for conditions that currently lack approved therapy options. The company's product is flexible, biodegradable, and adhesive to mucosal surfaces, and is designed with electrospinning technology, that delivers a therapeutic directly to the site in need, without interfering with the patient's daily activities, enabling patients to get relief and facilitating the recovery time required for mucosal lesions.
Contact Information
Website
www.afyxtx.comCorporate Office
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
Corporate Office
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
AFYX Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 09-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 24-Jun-2019 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 01-Jan-2019 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 08-May-2017 | Completed | Startup | |||
| 2. Grant | $1.95M | Completed | Startup | |||
| 1. Early Stage VC | 31-Dec-2015 | $1.95M | $1.95M | Completed | Startup |
AFYX Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A | ||||||||
| Class A |
AFYX Therapeutics Comparisons
Industry
Financing
Details
AFYX Therapeutics Competitors (1)
One of AFYX Therapeutics’s competitors is Apeptico, a Formerly VC-backed company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apeptico | Formerly VC-backed | Vienna, Austria |
AFYX Therapeutics Patents
AFYX Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260272942-A1 | Combining nimorazole, chemotherapy and radiotherapy | Pending | 14-Mar-2025 | ||
| EP-4827873-A1 | Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer | Pending | 14-Mar-2025 | ||
| WO-2026189632-A1 | Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer | Pending | 14-Mar-2025 | ||
| WO-2026189634-A1 | Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer | Pending | 14-Mar-2025 | ||
| WO-2023094457-A1 | Mucosal patches and methods of use thereof | Inactive | 23-Nov-2021 | A61K9/0034 |
AFYX Therapeutics Signals
AFYX Therapeutics Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EASME - EU Executive Agency for SMEs | Corporation | |||
| Innovationsfonden | Accelerator/Incubator | Minority | ||
| Lundbeckfonden | Limited Partner | Minority | ||
| Lundbeckfonden BioCapital | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority |
AFYX Therapeutics FAQs
-
When was AFYX Therapeutics founded?
AFYX Therapeutics was founded in 2013.
-
Where is AFYX Therapeutics headquartered?
AFYX Therapeutics is headquartered in Copenhagen, Denmark.
-
What is the size of AFYX Therapeutics?
AFYX Therapeutics has 7 total employees.
-
What industry is AFYX Therapeutics in?
AFYX Therapeutics’s primary industry is Drug Delivery.
-
Is AFYX Therapeutics a private or public company?
AFYX Therapeutics is a Private company.
-
What is AFYX Therapeutics’s current revenue?
The current revenue for AFYX Therapeutics is .
-
How much funding has AFYX Therapeutics raised over time?
AFYX Therapeutics has raised $32.4M.
-
Who are AFYX Therapeutics’s investors?
EASME - EU Executive Agency for SMEs, Innovationsfonden, Lundbeckfonden, Lundbeckfonden BioCapital, and Novo Holdings are 5 of 8 investors who have invested in AFYX Therapeutics.
-
Who are AFYX Therapeutics’s competitors?
Apeptico is a competitor of AFYX Therapeutics.
-
When was AFYX Therapeutics acquired?
AFYX Therapeutics was acquired on 09-Jan-2024.
-
Who acquired AFYX Therapeutics?
AFYX Therapeutics was acquired by Inphena.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process